Medical devices, healthcare technology and the business of care
PMA approval · P030036

MEDTRONIC SELECTSECURE LEAD MODEL 3830

Medtronic Cardiac Rhythm Disease Management · Decision date Aug 3, 2005

MEDTECHLEDGER EXPLANATIONP030036

What did the FDA approve?

The FDA approval statement for P030036 covers the Medtronic SelectSecure Lead Model 3830. The stated scope is that the lead has applications where implantable atrial or ventricular, single-chamber or dual-chamber pacing systems are indicated, and it is intended for pacing and sensing in the atrium or ventricle.

The record identifies the device category as drug eluting permanent right ventricular or right atrial pacemaker electrodes, with product code NVN and specialty Cardiovascular. The statement does not include clinical data, safety findings, or effectiveness results, so those details are absent from this source.

FDA approval order statement

APPROVAL FOR THE SELECTSECURE LEAD MODEL 3830. THE MODEL 3830 LEAD HAS APPLICATIONS WHERE IMPLANTABLE ATRIAL OR VENTRICULAR, SINGLE-CHAMBER OR DUAL-CHAMBER PACING SYSTEMS ARE INDICATED. THE MODEL 3830 LEAD IS INTENDED FOR PACING AND SENSING IN THE ATRIUM OR VENTRICLE.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Aug 3, 2005

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P030036
Regulatory pathway
Premarket approval application
Product code
NVN
Decision code
APPR
Decision date
Aug 3, 2005
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.

Product code
NVN
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P030036 received

    Application receipt date recorded by FDA.

  2. P030036 · FDA decision

    APPR

  3. P030036/S162 · Related supplement

    MEDTRONIC SELECTSECURE LEAD MODEL 3830

Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030036

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Cardiac Rhythm Disease ManagementPMA supplementOct 16, 2026FDA

Explore the linked device profile

Other records with product code NVN

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 9, 2026FDA
ABBOTT MEDICALPMA approvalJun 20, 1997FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Cardiac Rhythm Disease Management

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records